首页> 外国专利> APPLICATION OF TETRAHYDROFOLATES OF NATURAL STEREOISOMER FORM AT OBTAINING PHARMACEUTICAL COMPOSITION INDICATED TO AFFECT HOMOCYSTEINE LEVEL, TO MAINTAIN THE PROCESS OF HOMOCYSTEINE REMETHYLATION, IN PARTICULAR

APPLICATION OF TETRAHYDROFOLATES OF NATURAL STEREOISOMER FORM AT OBTAINING PHARMACEUTICAL COMPOSITION INDICATED TO AFFECT HOMOCYSTEINE LEVEL, TO MAINTAIN THE PROCESS OF HOMOCYSTEINE REMETHYLATION, IN PARTICULAR

机译:天然立体异构体形式的四氢叶酸在获得影响同型半胱氨酸水平的药物成分中的应用,尤其用于保持同型半胱氨酸再甲基化的过程

摘要

FIELD: pharmaceutics. SUBSTANCE: it is suggested to apply tetrahydrofolates of natural stereoisomer form previously known as inhibitors of thrombocyte aggregation, as active substance to obtain pharmaceutic composition indicated to affect homocysteine level, to decrease hyperhomocysteinemia, as well at preventing and treating cardiovascular diseases or at preventing disorders of nervous tube, and, also, pharmaceutical compositions based upon the abovementioned tetrahydrofolates and vitamins of B6 and/or B12 group. The present innovation increases the number of preparations of the mentioned indication. EFFECT: higher efficiency of application. 9 cl, 10 ex
机译:领域:药剂学。物质:建议使用以前被称为血小板聚集抑制剂的天然立体异构体形式的四氢叶酸作为活性物质,以获得可影响同型半胱氨酸水平,降低高同型半胱氨酸血症以及预防和治疗心血管疾病或预防心血管疾病的药物组合物。神经管,以及基于上述四氢叶酸和B6和/或B12组维生素的药物组合物。本发明增加了所述适应症的制剂数量。效果:更高的应用效率。 9厘升,10前

著录项

  • 公开/公告号RU2226099C2

    专利类型

  • 公开/公告日2004-03-27

    原文格式PDF

  • 申请/专利权人

    申请/专利号RU19980111617

  • 申请日1998-06-10

  • 分类号A61K31/519;A61K31/4415;A61K31/555;A61P43/00;A61P9/00;A61P7/00;

  • 国家 RU

  • 入库时间 2022-08-21 22:45:05

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号